Literature DB >> 26629010

MiR-592 represses FOXO3 expression and promotes the proliferation of prostate cancer cells.

Zhonghua Lv1, Pinlang Rao2, Wenlin Li3.   

Abstract

Prostate cancer (PC) is a serious health problem all over the world. Cell proliferation plays a major role in the tumorigenesis of PC. It is reported that microRNAs (miRNAs) played crucial roles in the regulation of cell proliferation. However, the underlying mechanism of miRNAs in PC has not been intensively investigated. In the present study, the effect of miR-592 on the cell proliferation of PC was investigated. The results showed that miR-592 was significantly upregulated in PC cell and PC tissues. To investigate the biological roles of miR-592, we induced either the up- or downregulation of miR-592 expression by transfecting DU145 PC cells with miR-592 mimics or miR-592 inhibitor. Our results demonstrated that the upregulation of miR-592promoted cell growth, while miR-592 inhibitor showed the opposite effect. Further experiment revealed that miR-592 repressed the expression of FOXO3 by directly targeting the 3'UTR of the FOXO3 transcript, which resulted in upregulating of the expression of cyclin D1 and downregulating of the expression of p21. In sum, our data indicated a novel aspect of the miR-592 in the molecular etiology of PC.

Entities:  

Keywords:  FOXO3; cell proliferation; miR-592; prostate cancer

Year:  2015        PMID: 26629010      PMCID: PMC4658899     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  25 in total

1.  Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer.

Authors:  Mulin Liu; Qiaoming Zhi; Wenbin Wang; Qiao Zhang; Taotao Fang; Qingyong Ma
Journal:  Biomed Pharmacother       Date:  2014-12-12       Impact factor: 6.529

2.  Tumor-suppressive microRNA-497 targets IKKβ to regulate NF-κB signaling pathway in human prostate cancer cells.

Authors:  Xiang-Jie Kong; Liu-Jian Duan; Xiao-Qiang Qian; Ding Xu; Hai-Long Liu; Ying-Jian Zhu; Jun Qi
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

3.  MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression.

Authors:  Shuo Chen; Xi Chen; Yin-Ling Xiu; Kai-Xuan Sun; Yang Zhao
Journal:  Cancer Lett       Date:  2015-03-25       Impact factor: 8.679

4.  MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.

Authors:  Fei Shen; Wen-Song Cai; Zhe Feng; Jiang-Lin Li; Ji-Wei Chen; Jie Cao; Bo Xu
Journal:  Tumour Biol       Date:  2014-11-19

5.  miR-892a regulated PPP2R2A expression and promoted cell proliferation of human colorectal cancer cells.

Authors:  Wen-long Liang; Jie Cao; Bo Xu; Ping Yang; Fei Shen; Zheng Sun; Wang-lin Li; Qiang Wang; Feng Liu
Journal:  Biomed Pharmacother       Date:  2015-04-27       Impact factor: 6.529

Review 6.  Oncomirs - microRNAs with a role in cancer.

Authors:  Aurora Esquela-Kerscher; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

7.  Expression of microRNA-96 and its potential functions by targeting FOXO3 in non-small cell lung cancer.

Authors:  Juan Li; Ping Li; Tengfei Chen; Ge Gao; Xiaonan Chen; Yuwen Du; Ren Zhang; Rui Yang; Wei Zhao; Shaozhi Dun; Feng Gao; Guojun Zhang
Journal:  Tumour Biol       Date:  2014-10-07

8.  MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts.

Authors:  Daren Wang; Hui Zhang; Min Li; Maria G Frid; Amanda R Flockton; B Alexandre McKeon; Michael E Yeager; Mehdi A Fini; Nicholas W Morrell; Soni S Pullamsetti; Sivareddy Velegala; Werner Seeger; Timothy A McKinsey; Carmen C Sucharov; Kurt R Stenmark
Journal:  Circ Res       Date:  2013-10-11       Impact factor: 17.367

9.  MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5.

Authors:  Yuan Fang; Xiaoxia Zhu; Jian Wang; Na Li; Dianhe Li; Nazmus Sakib; Zhou Sha; Wen Song
Journal:  Oncotarget       Date:  2015-05-30

10.  Tumor suppressive microRNA-137 negatively regulates Musashi-1 and colorectal cancer progression.

Authors:  Amber R Smith; Rebecca T Marquez; Wei-Chung Tsao; Surajit Pathak; Alexandria Roy; Jie Ping; Bailey Wilkerson; Lan Lan; Wenjian Meng; Kristi L Neufeld; Xiao-Feng Sun; Liang Xu
Journal:  Oncotarget       Date:  2015-05-20
View more
  16 in total

1.  Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes.

Authors:  Ronja S Adam; Dennis Poel; Leandro Ferreira Moreno; Joey M A Spronck; Tim R de Back; Arezo Torang; Patricia M Gomez Barila; Sanne Ten Hoorn; Florian Markowetz; Xin Wang; Henk M W Verheul; Tineke E Buffart; Louis Vermeulen
Journal:  Mol Oncol       Date:  2022-04-29       Impact factor: 7.449

2.  miR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth.

Authors:  Yan-Yan Jia; Jin-Yi Zhao; Bing-Ling Li; Kai Gao; Ying Song; Mei-You Liu; Xiao-Juan Yang; Yan Xue; Ai-Dong Wen; Lei Shi
Journal:  Oncotarget       Date:  2016-06-07

3.  MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity.

Authors:  Yang Wang; Ning Shao; Xueying Mao; Minmin Zhu; Weifei Fan; Zhixiang Shen; Rong Xiao; Chuncai Wang; Wenping Bao; Xinyu Xu; Chun Yang; Jian Dong; Deshui Yu; Yan Wu; Caixia Zhu; Liting Wen; Xiaojie Lu; Yong-Jie Lu; Ninghan Feng
Journal:  Oncotarget       Date:  2016-07-26

4.  High expression of Ras-related protein 1A promotes an aggressive phenotype in colorectal cancer via PTEN/FOXO3/CCND1 pathway.

Authors:  Liguo Liu; Xuebing Yan; Dapeng Wu; Yi Yang; Mengcheng Li; Yang Su; Wenchao Yang; Zezhi Shan; Yuping Gao; Zhiming Jin
Journal:  J Exp Clin Cancer Res       Date:  2018-07-31

5.  Somatic Mutations in miRNA Genes in Lung Cancer-Potential Functional Consequences of Non-Coding Sequence Variants.

Authors:  Paulina Galka-Marciniak; Martyna Olga Urbanek-Trzeciak; Paulina Maria Nawrocka; Agata Dutkiewicz; Maciej Giefing; Marzena Anna Lewandowska; Piotr Kozlowski
Journal:  Cancers (Basel)       Date:  2019-06-08       Impact factor: 6.639

6.  A Radiogenomic Approach for Decoding Molecular Mechanisms Underlying Tumor Progression in Prostate Cancer.

Authors:  Sarah Fischer; Mohamed Tahoun; Bastian Klaan; Kolja M Thierfelder; Marc-André Weber; Bernd J Krause; Oliver Hakenberg; Georg Fuellen; Mohamed Hamed
Journal:  Cancers (Basel)       Date:  2019-09-02       Impact factor: 6.639

7.  miR‑592 acts as an oncogene and promotes medullary thyroid cancer tumorigenesis by targeting cyclin‑dependent kinase 8.

Authors:  Ting Liu; Jingjing Meng; Yu Zhang
Journal:  Mol Med Rep       Date:  2020-07-30       Impact factor: 2.952

8.  Differentially expressed microRNAs between cattleyak and yak testis.

Authors:  Chuanfei Xu; Shixin Wu; Wangsheng Zhao; TserangDonko Mipam; Jingbo Liu; Wenjing Liu; Chuanping Yi; Mujahid Ali Shah; Shumin Yu; Xin Cai
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

Review 9.  Recent advances in understanding the role of FOXO3.

Authors:  Renae J Stefanetti; Sarah Voisin; Aaron Russell; Séverine Lamon
Journal:  F1000Res       Date:  2018-08-31

10.  Aberrant Expression of miR-592 Is Associated with Prognosis and Progression of Renal Cell Carcinoma.

Authors:  Xianbao Lv; Jingang Shen; Zhen Guo; Lingwei Kong; Guangchun Zhou; Hao Ning
Journal:  Onco Targets Ther       Date:  2019-12-18       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.